/ 2 items

#HOWL↓

HOWL/ 08/21/2026 · 8:31 AM

Werewolf and Ambros Merge in $150M Deal to Advance First Potential FDA-Approved Treatment for CRPS-1

Werewolf and Ambros merge in all-stock deal with oversubscribed $150M funding to advance neridronate as potential first FDA-approved CRPS-1 treatment.

HOWL/ 02/13/2026 · 4:40 PM

Werewolf Therapeutics' Big Changes: Staff Cuts and New Leadership

Werewolf Therapeutics announces a 64% workforce reduction to save money, key executives leave with severance, and a new finance officer steps in as the company explores partnerships and funding options.